BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22999555)

  • 1. Effects of transdermal testosterone in poor responders undergoing IVF: systematic review and meta-analysis.
    González-Comadran M; Durán M; Solà I; Fábregues F; Carreras R; Checa MA
    Reprod Biomed Online; 2012 Nov; 25(5):450-9. PubMed ID: 22999555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal testosterone pretreatment in poor responders undergoing ICSI: a randomized clinical trial.
    Bosdou JK; Venetis CA; Dafopoulos K; Zepiridis L; Chatzimeletiou K; Anifandis G; Mitsoli A; Makedos A; Messinis IE; Tarlatzis BC; Kolibianakis EM
    Hum Reprod; 2016 May; 31(5):977-85. PubMed ID: 26956551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
    Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
    Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis.
    Bosdou JK; Venetis CA; Kolibianakis EM; Toulis KA; Goulis DG; Zepiridis L; Tarlatzis BC
    Hum Reprod Update; 2012; 18(2):127-45. PubMed ID: 22307331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
    Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clomiphene citrate and letrozole to reduce follicle-stimulating hormone consumption during ovarian stimulation: systematic review and meta-analysis.
    Bechtejew TN; Nadai MN; Nastri CO; Martins WP
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):315-323. PubMed ID: 28236310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher live birth rate following transdermal testosterone pretreatment in poor responders: a systematic review and meta-analysis.
    Katsika ET; Bosdou JK; Goulis DG; Grimbizis GF; Kolibianakis EM
    Reprod Biomed Online; 2023 Jan; 46(1):81-91. PubMed ID: 36369150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
    Humaidan P; Chin W; Rogoff D; D'Hooghe T; Longobardi S; Hubbard J; Schertz J;
    Hum Reprod; 2017 Mar; 32(3):544-555. PubMed ID: 28137754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone therapy for women with poor ovarian response undergoing IVF: a meta-analysis of randomized controlled trials.
    Noventa M; Vitagliano A; Andrisani A; Blaganje M; Viganò P; Papaelo E; Scioscia M; Cavallin F; Ambrosini G; Cozzolino M
    J Assist Reprod Genet; 2019 Apr; 36(4):673-683. PubMed ID: 30610664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria.
    Polyzos NP; Blockeel C; Verpoest W; De Vos M; Stoop D; Vloeberghs V; Camus M; Devroey P; Tournaye H
    Hum Reprod; 2012 Dec; 27(12):3481-6. PubMed ID: 22940767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial.
    Youssef MA; van Wely M; Al-Inany H; Madani T; Jahangiri N; Khodabakhshi S; Alhalabi M; Akhondi M; Ansaripour S; Tokhmechy R; Zarandi L; Rizk A; El-Mohamedy M; Shaeer E; Khattab M; Mochtar MH; van der Veen F
    Hum Reprod; 2017 Jan; 32(1):112-118. PubMed ID: 27836979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique--a prospective, randomized, double-blind study.
    Massin N; Cedrin-Durnerin I; Coussieu C; Galey-Fontaine J; Wolf JP; Hugues JN
    Hum Reprod; 2006 May; 21(5):1204-11. PubMed ID: 16476678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical diminished ovarian reserve after endometrioma cystectomy versus idiopathic DOR: comparison of in vitro fertilization outcome.
    Roustan A; Perrin J; Debals-Gonthier M; Paulmyer-Lacroix O; Agostini A; Courbiere B
    Hum Reprod; 2015 Apr; 30(4):840-7. PubMed ID: 25740883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.
    Magnusson Å; Nilsson L; Oleröd G; Thurin-Kjellberg A; Bergh C
    Hum Reprod; 2017 Apr; 32(4):811-819. PubMed ID: 28175316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH.
    Balasch J; Fábregues F; Peñarrubia J; Carmona F; Casamitjana R; Creus M; Manau D; Casals G; Vanrell JA
    Hum Reprod; 2006 Jul; 21(7):1884-93. PubMed ID: 16517559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF: a systematic review and network meta-analysis.
    Zhang Y; Zhang C; Shu J; Guo J; Chang HM; Leung PCK; Sheng JZ; Huang H
    Hum Reprod Update; 2020 Feb; 26(2):247-263. PubMed ID: 32045470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial.
    Kolibianakis EM; Venetis CA; Bosdou JK; Zepiridis L; Chatzimeletiou K; Makedos A; Masouridou S; Triantafillidis S; Mitsoli A; Tarlatzis BC
    Hum Reprod; 2015 Feb; 30(2):432-40. PubMed ID: 25492411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.